Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta …

CL Vale, D Fisher, A Kneebone, C Parker, M Pearse… - The Lancet, 2020 - thelancet.com
Background It is unclear whether adjuvant or early salvage radiotherapy following radical
prostatectomy is more appropriate for men who present with localised or locally advanced …

[HTML][HTML] Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: a STOPCAP systematic review and meta-analysis

S Burdett, LM Boevé, FC Ingleby, DJ Fisher… - European urology, 2019 - Elsevier
Background Many trials are evaluating therapies for men with metastatic hormone-sensitive
prostate cancer (mHSPC). Objective To systematically review trials of prostate radiotherapy …

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

B Lacas, A Carmel, C Landais, SJ Wong… - Radiotherapy and …, 2021 - Elsevier
Abstract Background and purpose The Meta-Analysis of Chemotherapy in squamous cell
Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) …

Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma

Y Zhang, L Chen, GQ Hu, N Zhang… - … England Journal of …, 2019 - Mass Medical Soc
Background Platinum-based concurrent chemoradiotherapy is the standard of care for
patients with locoregionally advanced nasopharyngeal carcinoma. Additional gemcitabine …

[HTML][HTML] Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR …

D Arnold, B Lueza, JY Douillard, M Peeters, HJ Lenz… - Annals of oncology, 2017 - Elsevier
Background There is increasing evidence that metastatic colorectal cancer (mCRC) is a
genetically heterogeneous disease and that tumours arising from different sides of the colon …

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised …

YP Chen, X Liu, Q Zhou, KY Yang, F **, XD Zhu, M Shi… - The Lancet, 2021 - thelancet.com
Background Patients with locoregionally advanced nasopharyngeal carcinoma have a high
risk of disease relapse, despite a high proportion of patients attaining complete clinical …

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

M Bally, N Dendukuri, B Rich, L Nadeau… - bmj, 2017 - bmj.com
Objective To characterise the determinants, time course, and risks of acute myocardial
infarction associated with use of oral non-steroidal anti-inflammatory drugs (NSAIDs) …

Meta‐analysis using individual participant data: one‐stage and two‐stage approaches, and why they may differ

DL Burke, J Ensor, RD Riley - Statistics in medicine, 2017 - Wiley Online Library
Meta‐analysis using individual participant data (IPD) obtains and synthesises the raw,
participant‐level data from a set of relevant studies. The IPD approach is becoming an …

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

P Blanchard, A Lee, S Marguet, J Leclercq… - The lancet …, 2015 - thelancet.com
Background A previous individual patient data meta-analysis by the Meta-Analysis of
Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group to assess the …

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

B Lacas, J Bourhis, J Overgaard, Q Zhang… - The Lancet …, 2017 - thelancet.com
Summary Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of
Head and neck (MARCH) showed that altered fractionation radiotherapy is associated with …